A Randomized Placebo-Controlled Study to Evaluate the Effects of a Gummy and Capsule Supplement on Symptoms of Premenstrual Syndrome

Inclusion Criteria: * Female 18+ years of age. * Must be in good health with no significant chronic conditions (such as oncological or psychiatric disorders) and a BMI under 35. * Must experience at least five of the following symptoms during their menstrual cycle: Menstrual pain, Menstrual cramping, Increased Irritability, Mood changes, Breast tenderness, Headaches/migraines, Bloating, Fatigue, Constipation or diarrhea, Sleep disturbances * Must have a regular menstrual cycle with a bleed week, and must be currently tracking their menstrual cycle and able to accurately predict their bleed week. * If using hormonal contraception, must do so for at least three months before starting the trial, and remain consistent with taking it as per healthcare provider instructions during the study. * If using hormonal contraception, must allow for a bleed week every month. * Must agree to avoid cannabis, CBD, ashwagandha, and supplements other than multivitamins or protein powders for 24 hours prior to the study, and during the full study duration. * Willing to refrain from OTC pain medications or supplements to target period-related symptoms during the study period. * Must live in the United States. Exclusion Criteria: * Suffers from pre-existing conditions that would prevent them from adhering to the protocol. * Anyone currently undergoing or planning to undergo during the study period, any gynecological-related procedures. * Anyone diagnosed with Graves disease, Hashimotos or taking any medication for their thyroid. * Anyone who has undergone any surgeries or invasive treatments in the last six months, or is planning to during the study period. * Anyone with any allergic reactions requiring the use of an Epi-pen. * Anyone with known severe allergic reactions, or history of allergy or intolerance to ingredients found in over-the-counter dietary, vitamin or herbal supplements. * Anyone with any allergies or sensitivities to any of the study product ingredients. * Anyone with known allergies to nightshades (e.g., eggplant, tomato, bell pepper, potato). * Unwilling to follow the study protocol. * Anyone pregnant, breastfeeding, or trying to conceive currently or for the duration of the study. Participants will self-report that they are not pregnant. * Current use of an extended activity hormonal contraception (examples include Depo-Provera injection, Nexplanon implant, or hormonal intrauterine devices (IUDs)). * Currently participating in any other clinical study or planning to at any point during this study's duration. * Anyone who has an alcohol dependency, regularly uses cannabis, or is using illicit drugs. * Anyone with a history of substance abuse. * Anyone who regularly takes supplements that might reduce inflammation or is planning to at any point during the study period. * Anyone currently taking prescription pain medication for any indication. * Anyone who is currently taking, or planning to take during the study period, any medications, supplements or products targeted at improving Premenstrual Syndrome symptoms.